Literature DB >> 14752228

Microsatellite alterations in free-circulating serum DNA in patients with ulcerative colitis.

Peter Rauh1, Steffen Rickes, Michael Fleischhacker.   

Abstract

BACKGROUND/AIMS: The aim of this study was to find out whether there is free-circulating DNA in the serum of patients with ulcerative colitis and whether it is possible to establish a panel of genetic alterations which might be useful markers for diagnostic purposes, staging, or follow up.
METHODS: A set of 11 microsatellite markers located on different chromosomes were analyzed in a group of 59 patients with ulcerative colitis. Radiolabeled PCR products from serum and white blood cell DNA were analyzed by autoradiography and correlated with the clinical data from these patients.
RESULTS: Seven of 59 patients showed one or more microsatellite alteration(s) in their serum DNA. Six patients had an alteration in one marker, and two patients had changes in 4 markers, respectively. There was no correlation between the frequency of microsatellite alterations and the clinical data.
CONCLUSION: From the panel of 11 microsatellite markers used for these studies, 6 of them seem to be well suited for the detection of ulcerative colitis-associated alterations in free circulating serum DNA. In order to increase the specificity of this assay, it is necessary to increase the number of patients to be analyzed and to use a different set of markers. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14752228     DOI: 10.1159/000075361

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  4 in total

1.  Survival of HT29 Cancer Cells Is Affected by IGF1R Inhibition via Modulation of Self-DNA-Triggered TLR9 Signaling and the Autophagy Response.

Authors:  Ferenc Sipos; Bettina Bohusné Barta; Ágnes Simon; Lőrinc Nagy; Titanilla Dankó; Regina Eszter Raffay; Gábor Petővári; Viktória Zsiros; Barnabás Wichmann; Anna Sebestyén; Györgyi Műzes
Journal:  Pathol Oncol Res       Date:  2022-05-16       Impact factor: 2.874

2.  Preconditioning with intravenous colitic cell-free DNA prevents DSS-colitis by altering TLR9-associated gene expression profile.

Authors:  Györgyi Műzes; Ferenc Sipos; István Fűri; Miklós Constantinovits; Sándor Spisák; Barnabás Wichmann; Gábor Valcz; Zsolt Tulassay; Béla Molnár
Journal:  Dig Dis Sci       Date:  2014-09-13       Impact factor: 3.199

3.  Intravenous administration of a single-dose free-circulating DNA of colitic origin improves severe murine DSS-colitis.

Authors:  Ferenc Sipos; Györgyi Műzes; István Fűri; Sándor Spisák; Barnabás Wichmann; Tiana M Germann; Miklós Constantinovits; Tibor Krenács; Zsolt Tulassay; Béla Molnár
Journal:  Pathol Oncol Res       Date:  2014-04-11       Impact factor: 3.201

4.  Survival of HT29 cancer cells is influenced by hepatocyte growth factor receptor inhibition through modulation of self-DNA-triggered TLR9-dependent autophagy response.

Authors:  Bettina Bohusné Barta; Ágnes Simon; Lőrinc Nagy; Titanilla Dankó; Regina Eszter Raffay; Gábor Petővári; Viktória Zsiros; Anna Sebestyén; Ferenc Sipos; Györgyi Műzes
Journal:  PLoS One       Date:  2022-05-12       Impact factor: 3.752

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.